GLI1 and hepatocellular carcinoma: Indeed, GANT-61 has been verified to induce tumor-suppressing autophagic cell death in pancreatic ductal adenocarcinoma (PDAC) and hepatocellular carcinoma (HCC), which has been used to monitor the relationship between specific GLI targeting and autophagy [17, 37, 38].